Gilead Sciences Inc (NAS:GILD)
$ 67.66 -0.2 (-0.29%) Market Cap: 84.29 Bil Enterprise Value: 105.03 Bil PE Ratio: 187.94 PB Ratio: 4.81 GF Score: 77/100

Gilead Sciences Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2022 / 03:00PM GMT
Release Date Price: $62.38 (-0.26%)
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

All right. Well, thank you, everyone, and welcome to another great session here at the 2022 Jefferies in person. At Global Healthcare Conference, we're commenting at how great it is to see so many -- some friends and clients and everyone in person.

I'm very happy to have up with me here on the stage, the Chief Medical Officer of Gilead Sciences, Merdad Parsey. Long time no see. Since I just saw you at ASCO and obviously, a lot of exciting things going on in oncology for you as well. And so we're going to go through some of that as well as hopefully some other things.

Questions & Answers

Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

But maybe I would just take a step back and offer you the opportunity, since I think most people got the key highlights out of TRODELVY and ASCO, sort of a big picture question about how you feel about coming out of ASCO, your product profile for TRODELVY, how you guys feel about where we're going with that. Just make

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot